Design and Development of Water-Soluble Curcumin Conjugates as Potential Anticancer Agents-Reference-Cited by-同舟云学术

Design and Development of Water-Soluble Curcumin Conjugates as Potential Anticancer Agents

Published:2007-11-01 Issue:24 Volume:50 Page:6284-6288
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Safavy Ahmad¹,Raisch Kevin P.¹,Mantena Sushma¹,Sanford Leisa L.¹,Sham Simon W.¹,Krishna N. Rama¹,Bonner James A.¹

Affiliation:

1. Departments of Radiation Oncology, and Biochemistry and Molecular Genetics, and the Comprehensive Cancer Center (CCC), and the CCC NMR Core Facility, University of Alabama at Birmingham, Birmingham, Alabama 35294-6832.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm700988f

Reference24 articles.

1. Clinical trials of natural products as chemopreventive agents for prostate cancer

2. Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF-κB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells

3. Molecular targets of dietary agents for prevention and therapy of cancer

4. Curcumin: The story so far

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin – Bioavailability Enhancement by Prodrug Approach and Novel Formulations;Chemistry & Biodiversity;2024-04-16

2. Anti-gouty arthritis and anti-inflammatory effects of curcumin nanoparticles in monosodium urate crystals induced Balb/C mice;Inflammopharmacology;2024-03-31

3. In situ carbonization metamorphoses porous silica particles into biodegradable therapeutic carriers of lesser consequence on TGF-β1 mediated fibrosis;Nanoscale;2024

4. The Impact of Centrosome Pathologies on Ovarian Cancer Development and Progression with a Focus on Centrosomes as Therapeutic Target;Advances in Experimental Medicine and Biology;2024

5. Challenges associated with nanocurcumin anticancer drug delivery systems;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024